In individuals with and without type 2 diabetes, the expression of c7orf50 was robust throughout the intestines, with slightly higher levels in the large intestine (rectum: 5.2 ± 0.33 RPKM) compared to the small intestine (duodenum: 3.2 ± 0.2) (Figure 2A, Tables S6 and S7). This evidence concerns the gene CHLSN and type 2 diabetes mellitus.